We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDB icon
2676
HDFC Bank
HDB
$119B
-710,824
Closed -$19.9M
HGTY icon
2677
Hagerty
HGTY
$1.19B
-40,035
Closed -$366K
HLI icon
2678
Houlihan Lokey
HLI
$9.68B
-5,300
Closed -$679K
HLX icon
2679
Helix Energy Solutions
HLX
$1.46B
-153,516
Closed -$1.66M
HNI icon
2680
HNI Corp
HNI
$3B
-34,527
Closed -$1.56M
HON icon
2681
CALL
Honeywell
HON
$77.1B
-27,692
Closed -$5.3M
HON icon
2682
PUT
Honeywell
HON
$77.1B
-30,981
Closed -$5.93M
HR icon
2683
Healthcare Realty
HR
$7.42B
-439,073
Closed -$6.21M
HRB icon
2684
H&R Block
HRB
$5.18B
-82,637
Closed -$4.06M
HSTM icon
2685
HealthStream
HSTM
$793M
-13,323
Closed -$355K
IART icon
2686
Integra LifeSciences
IART
$1.54B
-26,709
Closed -$947K
IAS
2687
DELISTED
Integral Ad Science
IAS
-158,308
Closed -$1.58M
IAUX
2688
i-80 Gold Corp
IAUX
$1.17B
-40,359
Closed -$54.1K
IBM icon
2689
IBM
IBM
$202B
-120,582
Closed -$21M
ICLR icon
2690
Icon
ICLR
$12.8B
-139,768
Closed -$47M
IEF icon
2691
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
-3,550
Closed -$336K
IGF icon
2692
iShares Global Infrastructure ETF
IGF
$11B
-24,723
Closed -$1.18M
IGV icon
2693
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$13B
-25,500
Closed -$2.09M
IHS icon
2694
IHS Holding
IHS
$2.77B
-23,237
Closed -$82K
IMVT icon
2695
Immunovant
IMVT
$8.09B
-53,533
Closed -$1.73M
IMXI icon
2696
International Money Express
IMXI
$392M
-48,794
Closed -$1.11M
INFA
2697
DELISTED
Informatica
INFA
-98,505
Closed -$3.45M
INGR icon
2698
Ingredion
INGR
$6.38B
-2,465
Closed -$288K
INN
2699
Summit Hotel Properties
INN
$761M
-94,721
Closed -$617K
INO icon
2700
Inovio Pharmaceuticals
INO
$79.8M
-51,983
Closed -$722K

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.